Colleen F. Reitan
Director · MYRIAD GENETICS INC
- 2025
- Jun 5, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Colleen F. Reitan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Yvonne Greenstreet - $16.95M in ALNY purchases and sales in the last 12 months
- Kevin Joseph Fitzgerald - $8.24M in ALNY purchases and sales in the last 12 months
- Pushkal Garg - $4.88M in ALNY purchases and sales in the last 12 months
- Jeffrey V. Poulton - $2.22M in ALNY purchases and sales in the last 12 months
- Tolga Tanguler - $1.88M in ALNY purchases and sales in the last 12 months
- Melissa McLaughlin - $1.27M in ALNY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Colleen F. Reitan?
Colleen F. Reitan is a corporate insider, tracked as Director of MYRIAD GENETICS INC (MYGN). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Colleen F. Reitan last file a Form 4?
The most recent primary Form 4 on record is dated 5 June 2026, one of 4 filings going back to 2025.
Has Colleen F. Reitan been buying or selling stock?
Recorded transactions: 2 open-market purchases ($10K) and 17 open-market sales ($8.43M) across all tracked filings.
